
Marchex, Inc. (NASDAQ:MCHX – Free Report) – Stock analysts at Northland Capmk issued their Q4 2026 earnings per share estimates for shares of Marchex in a report released on Sunday, November 16th. Northland Capmk analyst M. Latimore anticipates that the technology company will earn ($0.01) per share for the quarter. The consensus estimate for Marchex’s current full-year earnings is ($0.10) per share.
Several other analysts also recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Marchex in a research report on Wednesday, October 8th. Zacks Research lowered shares of Marchex from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Reduce”.
Marchex Stock Performance
NASDAQ:MCHX opened at $1.45 on Wednesday. The company has a market capitalization of $64.06 million, a P/E ratio of -13.18 and a beta of 1.95. The stock’s 50 day moving average price is $1.80 and its 200 day moving average price is $1.87. Marchex has a 52 week low of $1.26 and a 52 week high of $2.40.
Hedge Funds Weigh In On Marchex
A number of institutional investors have recently made changes to their positions in the business. Marathon Capital Management lifted its holdings in shares of Marchex by 13.9% during the third quarter. Marathon Capital Management now owns 61,500 shares of the technology company’s stock worth $110,000 after buying an additional 7,500 shares during the last quarter. Jane Street Group LLC bought a new position in Marchex during the first quarter worth $30,000. Manatuck Hill Partners LLC bought a new position in Marchex during the second quarter worth $88,000. AMH Equity Ltd raised its stake in Marchex by 28.2% during the 2nd quarter. AMH Equity Ltd now owns 278,276 shares of the technology company’s stock valued at $609,000 after purchasing an additional 61,163 shares during the last quarter. Finally, Acuitas Investments LLC bought a new stake in Marchex in the 2nd quarter valued at $141,000. 73.46% of the stock is currently owned by institutional investors.
About Marchex
Marchex, Inc, a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance.
See Also
- Five stocks we like better than Marchex
- What is a Secondary Public Offering? What Investors Need to Know
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- Dividend Capture Strategy: What You Need to Know
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.
